ArticleMolecular cancer therapeutics2012

MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells.

Chin-Tung Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.